- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05403216
Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
Clinical Value of the Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
Study Overview
Detailed Description
For oral lichen planus patients, the prevalence of Hashimoto's thyroiditis will be investigated and the relationship between levels of anti-TG, anti-TPO antibodies and severity of oral lichen planus will be determined.
Besides, for patients with Hashimoto's thyroiditis, the prevalence of oral lichen planus will be investigated and the relationship between levels of anti-TG, anti-TPO antibodies and severity of oral lichen planus will be determined.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310014
- The Stomatology Hospital, Zhejiang University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- OLP patients without systemic disease
Exclusion Criteria:
- OLP patients with severe periodontal disease
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
OLP(-)
Oral lichen planus (OLP) with negative thyroid antibody group
|
|
|
OLP(+)
OLP with positive thyroid antibody group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral lichen planus (OLP) lesions record
Time Frame: 1 year
|
Record changes of lesions based on the symptoms and signs of the oral lichen planus patient.
|
1 year
|
|
Level of thyroid function and antibody
Time Frame: 1 year
|
The levels of thyroid hormone and thyroid autoantibodies in serum of OLP patients were detected.
|
1 year
|
Collaborators and Investigators
Investigators
- Study Chair: Qianming Chen, Dr., Zhejiang University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- I20210609
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.